SIRT4 and metabolic dysfunction-associated steatotic liver disease: In non-alcoholic fatty liver disease (NAFLD), SIRT4 deacetylates and destabilizes mitochondrial trifunctional protein-alpha (MTPα), thereby affecting fatty acid β-oxidation (van Maarschalkerweerd et al., 2015).